Exdensur: FDA Approves New Twice-Yearly Medicine for Severe Asthma

Exdensur (depemokimab) is a new type of ultra long-acting biologic medicine approved by the FDA as an add-on maintenance treatment for severe eosinophilic asthma — a type of asthma linked to high levels of eosinophils… Read more

Cardamyst: FDA Approves Nasal Spray for Sudden Fast Heartbeats

Cardamyst (etripamil) is a new nasal spray for treating sudden episodes of fast heartbeats, known as paroxysmal supraventricular tachycardia (PSVT), and restoring a normal heart rhythm in adults.It is the first self-administered medicine approved by… Read more

Inlexzo: A New Bladder Cancer Treatment

Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle invasive bladder cancer… Read more

FDA Expands Approved Use of Vonvendi

Vonvendi is a lab-made version of von Willebrand factor (VWF), a protein your body needs for blood to clot.Affecting more than 3 million people in the U.S, von Willebrand disease (VWD) is a common inherited… Read more

FDA Approves Zanvastro for Rare Brain Disorder Alexander Disease

What Is Zanvastro and How Does It Work? The FDA has approved Zanvastro (zilganersen) to treat adults and children with Alexander disease. Alexander disease is a very rare and severe brain disorder that gets worse… Read more

FDA Approves Jideytro for Advanced ROS1-Positive Lung Cancer

The FDA has approved Jideytro (zidesamtinib), a medicine for adults with a type of lung cancer called non-small-cell lung cancer (NSCLC). This approval is for cancer that has spread within the chest or to other… Read more

FDA Approves Fayuvi, First Gene Therapy for Children With Sanfilippo Syndrome Type A

What Is Fayuvi and How Does It Work? The FDA has approved Fayuvi (rebisufligene etisparvovec) to treat brain-related symptoms in children with a rare genetic disease called Sanfilippo syndrome type A, also known as mucopolysaccharidosis… Read more

FDA Approves Kerendia for Adults With Type 1 Diabetes and Kidney Disease

What Is Kerendia and How Does It Work? The FDA has approved Kerendia (finerenone) for adults who have chronic kidney disease (CKD) linked to type 1 diabetes. CKD is a condition where the kidneys slowly… Read more

FDA Approves Hyrnuo as First Treatment Choice for Specific Type of Lung Cancer

What Is Hyrnuo and How Does It Work? The FDA has granted accelerated approval to Hyrnuo (sevabertinib) for adults with a specific type of advanced lung cancer. It is used for non-squamous non-small-cell lung cancer… Read more

FDA Approves Etcamah Combination for Advanced Breast Cancer

What Is Etcamah, and How Does It Work? The FDA has approved Etcamah (camizestrant) to treat adults with advanced breast cancer. It is used for tumors that are hormone receptor (HR)-positive and human epidermal growth… Read more